
ASPN Valuation
Aspen Aerogels Inc
ASPN Relative Valuation
ASPN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ASPN is overvalued; if below, it's undervalued.
Historical Valuation
Aspen Aerogels Inc (ASPN) is now in the Fair zone, suggesting that its current forward PS ratio of 4.11 is considered Fairly compared with the five-year average of 17.32. The fair price of Aspen Aerogels Inc (ASPN) is between 1.86 to 6.25 according to relative valuation methord.
Relative Value
Fair Zone
1.86-6.25
Current Price:3.86
Fair
68.08
PE
1Y
3Y
5Y
Trailing
Forward
12.80
EV/EBITDA
Aspen Aerogels Inc. (ASPN) has a current EV/EBITDA of 12.80. The 5-year average EV/EBITDA is -14.06. The thresholds are as follows: Strongly Undervalued below -96.13, Undervalued between -96.13 and -55.10, Fairly Valued between 26.98 and -55.10, Overvalued between 26.98 and 68.02, and Strongly Overvalued above 68.02. The current Forward EV/EBITDA of 12.80 falls within the Historic Trend Line -Fairly Valued range.
61.59
EV/EBIT
Aspen Aerogels Inc. (ASPN) has a current EV/EBIT of 61.59. The 5-year average EV/EBIT is 1.78. The thresholds are as follows: Strongly Undervalued below -70.28, Undervalued between -70.28 and -34.25, Fairly Valued between 37.81 and -34.25, Overvalued between 37.81 and 73.85, and Strongly Overvalued above 73.85. The current Forward EV/EBIT of 61.59 falls within the Overvalued range.
3.86
PS
Aspen Aerogels Inc. (ASPN) has a current PS of 3.86. The 5-year average PS is 4.01. The thresholds are as follows: Strongly Undervalued below -1.84, Undervalued between -1.84 and 1.08, Fairly Valued between 6.93 and 1.08, Overvalued between 6.93 and 9.86, and Strongly Overvalued above 9.86. The current Forward PS of 3.86 falls within the Historic Trend Line -Fairly Valued range.
17.41
P/OCF
Aspen Aerogels Inc. (ASPN) has a current P/OCF of 17.41. The 5-year average P/OCF is -10.03. The thresholds are as follows: Strongly Undervalued below -90.79, Undervalued between -90.79 and -50.41, Fairly Valued between 30.35 and -50.41, Overvalued between 30.35 and 70.74, and Strongly Overvalued above 70.74. The current Forward P/OCF of 17.41 falls within the Historic Trend Line -Fairly Valued range.
23.17
P/FCF
Aspen Aerogels Inc. (ASPN) has a current P/FCF of 23.17. The 5-year average P/FCF is -1.05. The thresholds are as follows: Strongly Undervalued below -101.48, Undervalued between -101.48 and -51.27, Fairly Valued between 49.16 and -51.27, Overvalued between 49.16 and 99.37, and Strongly Overvalued above 99.37. The current Forward P/FCF of 23.17 falls within the Historic Trend Line -Fairly Valued range.
Aspen Aerogels Inc (ASPN) has a current Price-to-Book (P/B) ratio of 1.09. Compared to its 3-year average P/B ratio of 2.08 , the current P/B ratio is approximately -47.45% higher. Relative to its 5-year average P/B ratio of 4.17, the current P/B ratio is about -73.73% higher. Aspen Aerogels Inc (ASPN) has a Forward Free Cash Flow (FCF) yield of approximately 0.01%. Compared to its 3-year average FCF yield of -24.12%, the current FCF yield is approximately -100.03% lower. Relative to its 5-year average FCF yield of -17.77% , the current FCF yield is about -100.04% lower.
1.03
P/B
Median3y
2.08
Median5y
4.17
0.01
FCF Yield
Median3y
-24.12
Median5y
-17.77
Competitors Valuation Multiple
The average P/S ratio for ASPN's competitors is 4.74, providing a benchmark for relative valuation. Aspen Aerogels Inc Corp (ASPN) exhibits a P/S ratio of 3.86, which is -18.54% above the industry average. Given its robust revenue growth of -37.77%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of ASPN decreased by 73.92% over the past 1 year. The primary factor behind the change was an increase in P/E Change from -1.17 to -1.00.
The secondary factor is the Margin Expansion, contributed -21.54%to the performance.
Overall, the performance of ASPN in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch

ICHR
Ichor Holdings Ltd
14.970
USD
-0.80%

ARR
ARMOUR Residential REIT Inc
16.830
USD
+1.51%

CMCO
Columbus McKinnon Corp
15.650
USD
0.00%

EVGO
EVgo Inc
3.420
USD
+0.15%

MFA
MFA Financial Inc
9.210
USD
+2.68%

JBSS
John B Sanfilippo & Son Inc
67.620
USD
-0.59%

CECO
CECO Environmental Corp
53.300
USD
-0.60%

FBRT
Franklin BSP Realty Trust Inc
9.910
USD
-0.70%

VMEO
Vimeo Inc
7.830
USD
+0.38%

PCRX
Pacira Biosciences Inc
22.050
USD
+4.50%
FAQ
Is Aspen Aerogels Inc (ASPN) currently overvalued or undervalued?
Aspen Aerogels Inc (ASPN) is now in the Fair zone, suggesting that its current forward PS ratio of 4.11 is considered Fairly compared with the five-year average of 17.32. The fair price of Aspen Aerogels Inc (ASPN) is between 1.86 to 6.25 according to relative valuation methord.







